Discover

UG
United-Guardian, Inc.
7.06
2 x 5.07
2 x 8.92
bid
ask
-
0.08
1.12%
2 @ 04:00 PM
7.08 +0.02 (0.28%)
Ytd14.61%
1y-12.08%
6.96
day range
7.06
5.58
52 week range
9.88
Open6.99Prev Close7.14Low6.96High7.06Mkt Cap32.44M
Vol4.73KAvg Vol4.96KEPS0.52P/E13.58Forward P/EN/A
Beta0.81Short Ratio0.54Inst. Own23.65%Dividend0.60Div Yield4.89
Ex Div Date07-23Earning08-1150-d Avg7.03200-d Avg6.781yr Est0.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-082024-0900.19N/AN/A
2024-08-092024-0600.21N/AN/A
2024-05-102024-0300.2N/AN/A
2024-03-222023-1200.16N/AN/A
2023-11-062023-0900.14N/AN/A
2023-08-112023-0600.1N/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
Profile
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Renaissance Technologies, LLC182.36K1.74M3.97%
2024-09-29Gamco Investors Inc158.50K1.51M3.45%
2024-09-29Vanguard Group Inc137.36K1.31M2.99%
2024-09-29Rodgers Brothers Inc.97.88K933.75K2.13%
2024-09-29Dimensional Fund Advisors LP77.23K736.77K1.68%
2024-09-29Teton Advisors, Inc54.76K522.42K1.19%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29EQ Advisors Trust-1290 VT Gamco Small Company Value Port151.00K1.44M3.29%
2024-09-29Vanguard Total Stock Market Index Fund79.20K755.53K1.72%
2024-09-29Teton Westwood Mighty Mites Fd54.76K522.42K1.19%
2024-09-29Vanguard Extended Market Index Fund52.42K500.06K1.14%
2024-09-29Gabelli Small Cap Growth Fund38.00K362.52K0.83%
2024-07-30DFA U.S. Micro Cap Series33.44K318.97K0.73%
Dividend
DividendDate
0.252026-02-09
0.252025-07-25
0.352025-02-10
0.352024-07-23
0.252024-02-09
0.12023-07-25
Split
SplitDate
6 : 51985-09-12
11 : 101985-02-26
105 : 1001984-04-17
105 : 1001984-04-16